State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
- PMID: 30657336
- PMCID: PMC7061293
- DOI: 10.1089/dia.2018.0384
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Erratum in
-
Correction to: Diabetes Technol Ther 2019;21(2):66-72.Diabetes Technol Ther. 2019 Apr;21(4):230. doi: 10.1089/dia.2018.0384.correx. Epub 2019 Mar 8. Diabetes Technol Ther. 2019. PMID: 30848935 Free PMC article. No abstract available.
Abstract
Objective: To provide a snapshot of the profile of adults and youth with type 1 diabetes (T1D) in the United States and assessment of longitudinal changes in T1D management and clinical outcomes in the T1D Exchange registry.
Research design and methods: Data on diabetes management and outcomes from 22,697 registry participants (age 1-93 years) were collected between 2016 and 2018 and compared with data collected in 2010-2012 for 25,529 registry participants.
Results: Mean HbA1c in 2016-2018 increased from 65 mmol/mol at the age of 5 years to 78 mmol/mol between ages 15 and 18, with a decrease to 64 mmol/mol by age 28 and 58-63 mmol/mol beyond age 30. The American Diabetes Association (ADA) HbA1c goal of <58 mmol/mol for youth was achieved by only 17% and the goal of <53 mmol/mol for adults by only 21%. Mean HbA1c levels changed little between 2010-2012 and 2016-2018, except in adolescents who had a higher mean HbA1c in 2016-2018. Insulin pump use increased from 57% in 2010-2012 to 63% in 2016-2018. Continuous glucose monitoring (CGM) increased from 7% in 2010-2012 to 30% in 2016-2018, rising >10-fold in children <12 years old. HbA1c levels were lower in CGM users than nonusers. Severe hypoglycemia was most frequent in participants ≥50 years old and diabetic ketoacidosis was most common in adolescents and young adults. Racial differences were evident in use of pumps and CGM and HbA1c levels.
Conclusions: Data from the T1D Exchange registry demonstrate that only a minority of adults and youth with T1D in the United States achieve ADA goals for HbA1c.
Keywords: Continuous glucose monitor use; Insulin pump use.; T1D Exchange registry.
Conflict of interest statement
No competing financial interests exist.
Figures



Comment in
-
State of Type 1 Diabetes Care in the United States in 2016-2018 from T1D Exchange Registry Data.Diabetes Technol Ther. 2019 Feb;21(2):62-65. doi: 10.1089/dia.2019.0008. Diabetes Technol Ther. 2019. PMID: 30707619 Free PMC article. No abstract available.
-
An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately.J Diabetes Sci Technol. 2020 Nov;14(6):983-986. doi: 10.1177/1932296819895083. Epub 2019 Dec 26. J Diabetes Sci Technol. 2020. PMID: 31876181 Free PMC article. No abstract available.
References
-
- Beck RW, Tamborlane WV, Bergenstal RM, et al. : The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383–4389 - PubMed
-
- Miller KM, Foster NC, Beck RW, et al. : Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971–978 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials